Autres langues AstraZeneca PLC NYSE

Actions

AZN

US0463531089

Produits pharmaceutiques

Temps réel estimé Cboe BZX 21:59:35 30/09/2026			Varia. 5j.	Varia. 1 janv.
161,73 ^USD	-1,51 %		-2,47 %	+76,49 %

16:46	Les développeurs de traitements amaigrissants se bousculent pour conquérir un marché lucratif où la concurrence s’intensifie	RE
14:20	Les grands laboratoires pharmaceutiques se tournent vers la Chine pour leurs accords de licence	RE

Autres langues

16:46	Weight-loss drug developers line up to tap lucrative market as competition heats up
14:20	Major drugmakers turn to China for licensing deals
09:29	Dizal Gets Initial $600 Million in Licensing Fees from AstraZeneca for Cancer Drug
29/09	AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says
29/09	European Equities Decline in Tuesday Trading; BlackRock, Vanguard Face Pressure as European Banks Launch ETFs
29/09	British Shares End Lower Amid Credit, Shop Price Inflation Reports; Vesuvius Surges
29/09	Global markets live: Nvidia, Meta, Anthropic, OpenAI, Boeing…
29/09	Afternoon Meeting: La renta variable desafía la presión
29/09	Aktien trotzen dem Druck
29/09	Pharma sector doubles down on AI to slash costs, timelines
29/09	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Investors Weigh Tech Rebound
29/09	Stocks Defy the Pressure
29/09	US Equity Futures Slightly Higher Pre-Bell Amid Elevated Treasury Yields, Lack of Progress in US-Iran Talks
29/09	Stocks Rise Pre-Bell as Investors Weigh Growing AI Safety Concerns
29/09	S&P 500 flat as higher bond yields counter tech optimism
29/09	Borsa Usa, futures stabili, rimbalzo tech si scontra con cautela su greggio
29/09	Top Premarket Gainers
29/09	Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial Collaboration
29/09	Summit soars after $2 billion investment from AstraZeneca for cancer therapies
29/09	AstraZeneca invests $2bn in Summit Therapeutics
29/09	US stock futures flat as tech bounce meets crude-driven caution
29/09	FTSE 100 hits two-week low as energy stocks slide
29/09	WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook
29/09	Hutchmed says AstraZeneca files US application for Orpathys
29/09	Hutchmed Lung-Cancer Fighting Drug Submitted to FDA for Approval